These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2900827)

  • 61. A single point mutation responsible for c-mos polymorphism in cancer patients.
    Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Energy balance, insulin-related genes and risk of colon and rectal cancer.
    Slattery ML; Murtaugh M; Caan B; Ma KN; Neuhausen S; Samowitz W
    Int J Cancer; 2005 May; 115(1):148-54. PubMed ID: 15688407
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence that the familial adenomatous polyposis gene is involved in a subset of colon cancers with a complementable defect in c-myc regulation.
    Erisman MD; Scott JK; Astrin SM
    Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4264-8. PubMed ID: 2542967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Restriction fragment length polymorphisms of the human N-myc gene: relationship to gene amplification.
    Kurosawa H; Yamada M; Nakagome Y
    Oncogene; 1987; 2(1):85-90. PubMed ID: 2894002
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
    Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
    Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Taq I RFLP linked to the human ets-1 gene.
    Aparicio JM; Wakisaka A; Takada A; Matsuura N; Yoshiki T
    Nucleic Acids Res; 1989 Jun; 17(12):4913. PubMed ID: 2568621
    [No Abstract]   [Full Text] [Related]  

  • 67. A study of c-myc oncogene expression and amplification in colorectal cancer.
    Wang J; Li L; Li S; Cui H; Shen G
    Chin Med Sci J; 1994 Mar; 9(1):24-8. PubMed ID: 8086630
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The analysis of restriction fragment length polymorphism in human cancer: a review from an epidemiological perspective.
    Vineis P; Caporaso N
    Int J Cancer; 1991 Jan; 47(1):26-30. PubMed ID: 1670765
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Chromosomal markers in study of colon cancer.
    Wolman SR
    Dig Dis Sci; 1985 Dec; 30(12 Suppl):134S-140S. PubMed ID: 3864630
    [No Abstract]   [Full Text] [Related]  

  • 70. Colorectal cancer in spouses of colorectal cancer patients and controls.
    Kune GA; Kune S; Watson LF
    Lancet; 1987 Apr; 1(8537):870-1. PubMed ID: 2882280
    [No Abstract]   [Full Text] [Related]  

  • 71. Genetic aspects of carcinogenesis.
    Sheer D
    Br J Surg; 1985 Sep; 72 Suppl():S39-41. PubMed ID: 3899256
    [No Abstract]   [Full Text] [Related]  

  • 72. L-myc restriction fragment length polymorphism in Japanese patients with esophageal cancer.
    Shibuta K; Inoue H; Sato K; Matsuyama A; Ueo H; Tanaka Y; Mafune K; Barnard GF; Mori M
    Jpn J Cancer Res; 2000 Feb; 91(2):199-203. PubMed ID: 10761707
    [TBL] [Abstract][Full Text] [Related]  

  • 73. MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer.
    Fong KM; Kida Y; Zimmerman PV; Smith PJ
    Br J Cancer; 1996 Dec; 74(12):1975-8. PubMed ID: 8980399
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor.
    Zborovskaya I; Gasparian A; Kitaeva M; Polotzky B; Tupitzin N; Machaladze Z; Gerasimov S; Shtutman M; Jakubovskaya M; Davidov M; Tatosyan A
    Clin Exp Metastasis; 1996 Nov; 14(6):490-500. PubMed ID: 8970579
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Coamplification of the L-myc and N-myc oncogenes in a neuroblastoma cell line.
    Jinbo T; Iwamura Y; Kaneko M; Sawaguchi S
    Jpn J Cancer Res; 1989 Apr; 80(4):299-301. PubMed ID: 2501244
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
    Tefre T; Børresen AL; Aamdal S; Brøgger A
    Br J Cancer; 1990 Jun; 61(6):809-12. PubMed ID: 1973618
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Restriction fragment length polymorphism of the L-myc gene in oral cancer patients.
    Saranath D; Panchal RG; Nair R; Mehta AR; Sanghavi V; Deo MG
    Br J Cancer; 1990 Apr; 61(4):530-3. PubMed ID: 1970484
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx.
    Dolcetti R; Pelucchi S; Maestro R; Rizzo S; Pastore A; Boiocchi M
    Eur Arch Otorhinolaryngol; 1991; 248(5):279-85. PubMed ID: 1679639
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship of H-ras-1, L-myc, and p53 polymorphisms with lung cancer risk and prognosis.
    Weston A; Caporaso NE; Perrin LS; Sugimura H; Tamai S; Krontiris TG; Trump BF; Hoover RN; Harris CC
    Environ Health Perspect; 1992 Nov; 98():61-7. PubMed ID: 1486864
    [TBL] [Abstract][Full Text] [Related]  

  • 80. No correlation between L-myc restriction fragment length polymorphism and malignancy of human colorectal cancers.
    Ikeda I; Ishizaka Y; Ochiai M; Sakai R; Itabashi M; Onda M; Sugimura T; Nagao M
    Jpn J Cancer Res; 1988 Jun; 79(6):674-6. PubMed ID: 2900827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.